Agilent’s Non-Small Cell Lung Cancer Companion Dx Receives Expanded FDA Approval

News   Oct 25, 2016

 
Agilent’s Non-Small Cell Lung Cancer Companion Dx Receives Expanded FDA Approval
 
 
 

RELATED ARTICLES

New Technique Overcomes Genetic Cause of Infertility

News

Scientists have created healthy offspring from genetically infertile male mice, offering a potential new approach to tackling a common genetic cause of human infertility.

READ MORE

Self-powered, Paper-based Electrochemical Devices Developed for POC Diagnostics

News

The new paper-based diagnostic device detects biomarkers and identifies diseases by performing electrochemical analyses, and the assays change color to indicate specific test results.

READ MORE

Blood Test Predicts Prostate Tumor Resistance

News

A new blood test developed by researchers at the Technical University of Munich (TUM) can predict drug resistance in patients with advanced prostate cancer.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE